{"id":"W2560750372","doi":"10.1200/jco.2011.29.7_suppl.241","title":"Results of a phase II study of single-agent nab-paclitaxel in platinum-refractory second-line metastatic urothelial carcinoma (UC).","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; London Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Nausea; Tolerability; Docetaxel; Response Evaluation Criteria in Solid Tumors; Paclitaxel; Progressive disease; Refractory (planetary science); Gastroenterology; Adverse effect; Phases of clinical research; Chemotherapy; Metastatic Urothelial Carcinoma; Oncology; Performance status; Surgery; Cancer; Bladder cancer; Urothelial carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003240904,0.001447798,0.002543911,0.0004489312,0.0005169607,0.001122722,0.001164279,0.001622266,0.003006673],"category_scores_gemma":[0.001546334,0.0007024502,0.001322696,0.0004506542,0.000978564,0.0008139167,0.000304778,0.003411441,0.001125501],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007968252,"about_ca_system_score_gemma":0.001653993,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009546152,"about_ca_topic_score_gemma":0.001636682,"domain_scores_codex":[0.999283,0.0003890354,0.00004340005,0.00009881128,0.0000711897,0.0001145262],"domain_scores_gemma":[0.9984246,0.0003273727,0.0002241458,0.0001669185,0.0001177925,0.0007391531],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5763165,0.191298,0.01200275,0.001175709,0.00289835,0.000891902,0.0006006313,0.003780019,0.1116256,0.0001979674,0.007672597,0.09154002],"study_design_scores_gemma":[0.4180217,0.5501966,0.01855514,0.00003007786,0.0009138692,0.0006072255,0.00006030918,0.001248459,0.007587015,0.0001400631,0.002601607,0.00003795937],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9915438,0.001749297,0.0006356511,0.0003824907,0.0001507452,0.002959608,0.00134148,0.00009596466,0.001140952],"genre_scores_gemma":[0.9856275,0.002008745,0.001916862,0.0007567095,0.0002208841,0.002672056,0.004495221,0.00006350272,0.00223842],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003240904,"threshold_uncertainty_score":0.01713973,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.275103562315213,"score_gpt":0.4665840911058216,"score_spread":0.1914805287906086,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}